1Zwaka TP, Hombach V, Torzewski J. C-reactive protein mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis[J]. Circulation, 2001, 103(9): 1194-1197.
2Yeh ET, Anderson HV, Pasceri V, et al. C-reactive protein linking inflammation to cardiovascular complications [J]. Circulation, 2001, 104(9): 974-975.
3Ridker PM, Stampfer M J, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine lipoprotein (a), and standard cholesterol screening predictors of peripheral arterial disease [J]. JAMA, 2001,285 (19): 2481-2485.
4Roberts WL, Moulton L, Law TC, et al. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2 [J]. Clin Chem, 2001, 47(3): 418-425.
5Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events[J]. N Engl J Med, 2002, 347(20): 1557-1565.
6Rifai N, Ridker PM. Population distributions of C-reactive protein apparently healthy men and women in the United States: implication for clinical interpretation[J]. Clin Chem, 2003, 49(4): 666-669.
7Verma S, Wang CH, Li SH, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis[J]. Cireulation, 2002, 106(8): 913-919.
8Verma S, Li SH, Badiwala MV, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-re.active protein[J]. Circulation, 2002, 105(16): 1890-1896.
9Agrawal A, Shrive AK, Greenhough T J, et al. Topology and structure of the Clq-binding site on C-reactive protein [J]. J Immunol, 2001, 166(6): 3998-4004.
10Torzewski M, Rist C, Mortensen RF, et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis [J]. Arterioscler Thromb Vasc Biol, 2000, 20(9): 2094-2099.
